The yin and yang of interleukin-2-mediated immunotherapy

Editorial

Jeffrey A Bluestone. N Engl J Med. 2011.

. 2011 Dec 1;365(22):2129-31.

doi: 10.1056/NEJMe1110900.

No abstract available

Comment on

Interleukin-2 and regulatory T cells in graft-versus-host disease.
Koreth J, Matsuoka K, Kim HT, McDonough SM, Bindra B, Alyea EP 3rd, Armand P, Cutler C, Ho VT, Treister NS, Bienfang DC, Prasad S, Tzachanis D, Joyce RM, Avigan DE, Antin JH, Ritz J, Soiffer RJ. Koreth J, et al. N Engl J Med. 2011 Dec 1;365(22):2055-66. doi: 10.1056/NEJMoa1108188. N Engl J Med. 2011. PMID: 22129252 Free PMC article. Clinical Trial.
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis.
Saadoun D, Rosenzwajg M, Joly F, Six A, Carrat F, Thibault V, Sene D, Cacoub P, Klatzmann D. Saadoun D, et al. N Engl J Med. 2011 Dec 1;365(22):2067-77. doi: 10.1056/NEJMoa1105143. N Engl J Med. 2011. PMID: 22129253 Clinical Trial.